Jacobs Levy Equity Management, Inc Castle Biosciences Inc Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 496,521 shares of CSTL stock, worth $15.3 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
496,521
Previous 517,977
4.14%
Holding current value
$15.3 Million
Previous $11.3 Million
25.58%
% of portfolio
0.06%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding CSTL
# of Institutions
200Shares Held
25.9MCall Options Held
292KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$93.9 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$56.3 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$53.9 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$47.4 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$38.9 Million0.61% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $811M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...